<img height="1" width="1" style="display:none" src="https://q.quora.com/_/ad/b20db0d9ec224ca9ade49b26500b826e/pixel?tag=ViewContent&amp;noscript=1">
Probiotics & Weight Loss: Study Examines Fragmented Lactobacillus Strain

Last updated: February-1,2021

Probiotics & Weight Loss: Study Examines Fragmented Lactobacillus Strain

Lactobacillus Amylovorus & Weight Loss in Overweight Adults

A recently released Japanese studied has provided the health and wellness community with new evidence supporting the link between certain probiotics strains and weight loss.

Over the course of the 12-week trial, Japanese researcher examined the effects of Lactobacillus amylovorus CP1563 (or CP1563, for short) on 200 healthy adult volunteers with a body mass index (BMI) between 25 and 30.

During the trial, some of the participants received 200mg of CP1563 a day via a test beverage while the placebo group received the same beverage, but without the 200mg of CP156. Along with receiving the test beverages, participants were asked to maintain their normal, healthy lifestyle – which included diet and exercise. At the end of the 12 weeks, 197 of the 200 participants were able to complete the trial without any adverse effects.

Lactobacillus & Weight Loss: The Study's Results

After tallying up all the results, the pointed to a number of interesting potential correlations. Here's the highlight reel of what the researchers found:

  • Body fat percentage, whole body fat, and visceral fat all saw a significant decreased in the test group when compared with the placebo group.
  • Triglycerides, total cholesterol, LDL-cholesterol, and diastolic blood pressure saw noteworthy reductions in the test group.
  • Blood glucose and insulin levels were also positively affected for the participants in the test group.

The Study's Conclusion

To borrow from the authors of the study, here are the key conclusory notes:

Daily consumption of beverages containing fragmented CP1563 for 12 weeks by obese class I subjects improved anthropometric measurements and markers related to lipid and glucose metabolism without any adverse effects. These results suggest that the consumption of foods containing fragmented CP1563 reduces body fat and prevents metabolic syndrome.

To recap in plain English: The data available suggests that supplementation of CP1563 at 200mg/day of the course of 12 weeks play a role in positively reducing the levels of lipids (think fats) and our glucose metabolism (think sugars & insulin) in those who are overweight or mildly obese.

The Takeaway for Probiotics Manufacturers

It doesn't look like consumer or industry interest in probiotics will (or should) diminish any time soon. With dozens of studies suggesting that probiotics may support a number of different areas of human health – including, but not limited to weight loss – it's almost always possible to work with your manufacturer to formulate the perfect probiotics blend for your customers' needs.

Looking for more? Click here to check out this blog post on global probiotic demand!


  1. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879181/
April 12th, 2017

About the Author:

Melissa DellaBartolomea

Melissa DellaBartolomea was the resident Content Marketing Specialist at NutraScience Labs from February 2016 to July 2018. Driven by a passion for the world of written, visual, and digital media, she's dedicated herself to keeping up with all things nutraceutical. From ingredient insights to the latest in contract manufacturing regulations and trends, her mission is to provide our readers (like you) with the stories and knowledge they need to fuel long-term growth and nutraceutical industry success.